ATS Corp /ATS
ATS NYSE General Industrial Machinery & Equipment, Nec Financials FY2023–FY2026
Last close · Oct 23, 2026
$18.94
0.8%What ATS Corp /ATS does
No business description yet.
- Legal name
- ATS Corp /ATS
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 40-F · May 28, 2026
- Accession · CIK
- 0001394832-26-000015
0001394832
Revenue and margins
ATS Corp /ATS had $2.2B of revenue in fiscal 2026, up 18.1% on the year before.
Net income and earnings per share
From fiscal 2023 to 2026, diluted EPS grew −20.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $300M in fiscal 2026, 14.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
ATS Corp /ATS returned $7.2M to shareholders in fiscal 2026, 2% of free cash flow. The diluted share count rose 0.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably ATS Corp /ATS can carry it.
| Fiscal year end | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Cash and short-term investments | $118M | $125M | $157M | $204M |
| Debt incl. finance leases | $853M | $864M | $1.1B | $915M |
| Debt / equity | 1.0x | 0.7x | 0.9x | 0.7x |
| Interest coverage | 3.7x | 4.8x | 0.1x | 2.1x |
| Current ratio | 1.4x | 1.7x | 1.7x | 1.6x |
| Quick ratio | 1.1x | 1.4x | 1.4x | 1.4x |
| Total assets | $2.6B | $3.0B | $3.2B | $3.1B |
| Total liabilities | $1.8B | $1.8B | $2.0B | $1.8B |
| Shareholders' equity | $832M | $1.2B | $1.2B | $1.3B |
| Net debt (− = net cash) | $735M | $738M | $917M | $710M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✕ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✓ | ✕ | ✓ |
| Cash from operations exceeds net income | ✓ | ✕ | ✓ | ✓ |
| Debt fell relative to assets | — | ✓ | ✕ | ✓ |
| Current ratio rose | — | ✓ | ✕ | ✕ |
| Share count didn't rise | — | ✕ | ✓ | ✕ |
| Gross margin rose | — | ✓ | ✕ | ✓ |
| Revenue rose relative to assets | — | ✓ | ✕ | ✓ |
| F-score | — / 3 | 7 / 9 | 3 / 9 | 7 / 9 |
| Accruals ratio | −0.0% | 4.6% | −1.2% | −8.6% |
| Altman Z'' | 2.17 | 3.00 | 2.20 | 2.59 |
4 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $1.9B | $2.2B | $1.8B | $2.2B |
| Gross profit | $549M | $634M | $465M | $615M |
| Research and development | — | $7.6M | $7.6M | $12.0M |
| Operating income | $168M | $234M | $6.7M | $144M |
| Interest expense | $45.9M | $48.3M | $66.3M | $67.9M |
| Pretax income | $121M | $183M | −$59.6M | $71.8M |
| Income tax | $24.2M | $38.9M | −$39.5M | $19.9M |
| Net income | $96.3M | $144M | −$20.2M | $51.8M |
| Net income to common | $96.3M | $144M | −$20.2M | $51.8M |
| Diluted EPS | $1.04 | $1.46 | −$0.21 | $0.53 |
| Diluted shares | 0.09B | 0.10B | 0.10B | 0.10B |
| Cash flow | ||||
| Cash from operations | $96.6M | $15.4M | $18.5M | $324M |
| Capital expenditure | $42.4M | $43.6M | $24.4M | $24.3M |
| Free cash flow | $54.2M | −$28.2M | −$5.9M | $300M |
| Stock-based compensation | $3.8M | $8.3M | $7.6M | $3.7M |
| Share buybacks | $15.9M | $0.0M | $32.3M | $7.2M |
| Dividends and buybacks | $15.9M | $0.0M | $32.3M | $7.2M |
| Balance sheet | ||||
| Cash and short-term investments | $118M | $125M | $157M | $204M |
| Total debt | $853M | $864M | $1.1B | $915M |
| Current assets | $1.1B | $1.3B | $1.3B | $1.2B |
| Current liabilities | $770M | $758M | $784M | $745M |
| Inventory | $190M | $218M | $223M | $212M |
| Property and equipment, net | $194M | $219M | $226M | $186M |
| Goodwill | $825M | $905M | $971M | $1.0B |
| Intangible assets | $438M | $501M | $528M | $505M |
| Total assets | $2.6B | $3.0B | $3.2B | $3.1B |
| Total liabilities | $1.8B | $1.8B | $2.0B | $1.8B |
| Shareholders' equity | $832M | $1.2B | $1.2B | $1.3B |
| Margins | ||||
| Gross margin | 28.2% | 28.2% | 25.5% | 28.6% |
| Operating margin | 8.6% | 10.4% | 0.4% | 6.7% |
| Net margin | 4.9% | 6.4% | −1.1% | 2.4% |
| FCF margin | 2.8% | −1.3% | −0.3% | 14.0% |
| Returns | ||||
| Return on capital | 8.6% | 9.3% | 0.2% | 5.2% |
| Return on capital employed | 9.1% | 10.4% | 0.3% | 6.1% |
| Return on equity | 11.6% | 13.9% | −1.7% | 4.2% |
| Return on assets | 3.7% | 5.1% | −0.6% | 1.6% |
| Growth | ||||
| Revenue growth | — | 15.4% | −19.0% | 18.1% |
| Net income growth | — | 49.1% | −114.0% | — |
| EPS growth | — | 40.0% | −114.3% | — |
| FCF growth | — | −152.1% | — | — |
| Share count change | — | 6.9% | −0.6% | 0.2% |
| Financial health | ||||
| Debt / equity | 1.0x | 0.7x | 0.9x | 0.7x |
| Interest coverage | 3.7x | 4.8x | 0.1x | 2.1x |
| Current ratio | 1.4x | 1.7x | 1.7x | 1.6x |
| Quick ratio | 1.1x | 1.4x | 1.4x | 1.4x |
| Capital allocation | ||||
| Capex / revenue | 2.2% | 1.9% | 1.3% | 1.1% |
| Stock comp / revenue | 0.2% | 0.4% | 0.4% | 0.2% |
| Payouts / FCF | 29.4% | — | — | 2.4% |
| Quality scores | ||||
| Piotroski F-score | — | 7.0 | 3.0 | 7.0 |
| Altman Z'' | 2.2 | 3.0 | 2.2 | 2.6 |
| Accruals ratio | −0.0% | 4.6% | −1.2% | −8.6% |
Source: SEC EDGAR XBRL filings (CIK 0001394832). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in CAD under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.